Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only…
Mipsagargin (G-202), a new prodrug developed by GenSpera, has a unique mechanism of action that allows it to kill cancer cells without damaging surrounding tissues. Derived from thapsigargin,…
There are many ailments that can produce pain in the pelvic region, but one that is often overlooked or misdiagnosed is pelvic congestion syndrome (PCS). Affecting approximately 10%…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Hidradenitis suppurativa (HS) is a chronic skin condition that results in painful abscesses, nodules, inflamed follicles, and acne-like cysts on many sensitive epidermal surfaces of both men and…
Hidradenitis suppurativa (HS) is a disease of the follicle that results in painful lesions and abscesses on the skin, most often in the intertriginous areas of the body.…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Urinary incontinence (UI) is much more common than most might imagine, affecting nearly one-in-three women worldwide. UI, the occasional inability to prevent urine from leaking through one’s urethra,…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
